Purdue Pharma ’s Creditors Overwhelmingly Endorse Bankruptcy Plan
If approved by a judge next month, the plan would resolve thousands of lawsuits and set in motion the release of $4.5 billion to help cover costs from the opioid epidemic. (Source: NYT Health)
Source: NYT Health - July 27, 2021 Category: Consumer Health News Authors: Jan Hoffman Tags: your-feed-science Pain-Relieving Drugs Drug Abuse and Traffic OxyContin (Drug) Opioids and Opiates Drugs (Pharmaceuticals) Suits and Litigation (Civil) Purdue Pharma Sackler Family United States Source Type: news

Purdue Pharma ’s Creditors Vote Yes To Bankruptcy Deal Shielding Billionaire Owners From Future Opioid Lawsuits
The deal, which the OxyContin-maker says is worth $10 billion, is to settle thousands of lawsuits against the company for its alleged role in fueling the opioid crisis. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 27, 2021 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Billionaires /worlds-billionaires Innovation /innovation Healthcare /healthcare Breaking breaking-news Editors' Pick editors-pick Source Type: news

West Virginia opposes Purdue Pharma bankruptcy plan
West Virginia Attorney General Patrick Morrisey says he will oppose OxyContin maker Purdue Pharma’s bankruptcy plan (Source: ABC News: Health)
Source: ABC News: Health - July 14, 2021 Category: Consumer Health News Tags: Health Source Type: news

Purdue Pharma exit plan gains steam with OK from more states
OxyContin maker Purdue Pharma's plan to reorganize into an entity whose profits will be used to combat the U.S. opioid crisis got a big boost as 15 states have dropped their objections to the new business model (Source: ABC News: Health)
Source: ABC News: Health - July 8, 2021 Category: Consumer Health News Tags: Health Source Type: news

15 States Reach a Deal With Purdue Pharma Over Opioids
The states, including Massachusetts and New York, agreed to drop opposition to the bankruptcy organization plan of the company, the maker of OxyContin. (Source: NYT Health)
Source: NYT Health - July 8, 2021 Category: Consumer Health News Authors: Jan Hoffman Tags: Purdue Pharma Suits and Litigation (Civil) Pain-Relieving Drugs Bankruptcies Opioids and Opiates Drugs (Pharmaceuticals) Sackler Family your-feed-healthcare Compensation for Damages (Law) States (US) California Massachusetts New Yo Source Type: news

Purdue Pharma exit plan gains steam with OK from more states
OxyContin maker Purdue Pharma’s plan to reorganize into a new entity that helps combat the U.S. opioid epidemic got a big boost as 15... (Source: Reuters: Health)
Source: Reuters: Health - July 8, 2021 Category: Consumer Health News Source Type: news

More states agree to settlement plan for opioid-maker Purdue
More than a dozen states have dropped their objections to OxyContin maker Purdue Pharma’s reorganization plan, edging the company closer to resolving its bankruptcy case (Source: ABC News: Health)
Source: ABC News: Health - July 8, 2021 Category: Consumer Health News Tags: Health Source Type: news

Cincinnati attorney to play key role in OxyContin-maker's $4.5B settlement
A Cincinnati-based attorney has been appointed to a key role in the ongoing $4.5 billion settlement, and bankruptcy proceedings, with OxyContin maker Purdue Pharma. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 30, 2021 Category: Pharmaceuticals Authors: Andy Brownfield Source Type: news

Language Barriers May Contribute to Pain Management Disparities Language Barriers May Contribute to Pain Management Disparities
Patients whose first language is not English received fewer pain assessments and fewer doses of NSAIDs and oxycodone therapeutic equivalents following cesarean deliveries, new research suggestsMedscape Medical News (Source: Medscape Med Students Headlines)
Source: Medscape Med Students Headlines - June 10, 2021 Category: Universities & Medical Training Tags: Ob/Gyn & Women ' s Health News Source Type: news

InFocus: Microsphere Oxycodone Deters Abuse
No abstract available (Source: Emergency Medicine News)
Source: Emergency Medicine News - June 1, 2021 Category: Emergency Medicine Tags: InFocus Source Type: news

Judge Clears Purdue Pharma ’s Restructuring Plan for Vote by Thousands of Claimants
The ruling was a milestone in yearslong efforts to make the OxyContin manufacturer pay for its role in the opioid crisis, but some plaintiffs feel the plan doesn ’t go far enough. (Source: NYT Health)
Source: NYT Health - May 26, 2021 Category: Consumer Health News Authors: Jan Hoffman and Mary Williams Walsh Tags: your-feed-science Suits and Litigation (Civil) Bankruptcies Drug Abuse and Traffic OxyContin (Drug) Purdue Pharma Drain, Robert D Finances Sackler Family Source Type: news

Paul J. Hanly Jr., Top Litigator in Opioid Cases, Dies at 70
Mr. Hanly had been central to the current nationwide litigation against pharmaceutical companies, pharmacies and others in the opioid supply chain. (Source: NYT Health)
Source: NYT Health - May 22, 2021 Category: Consumer Health News Authors: Katharine Q. Seelye Tags: Hanly, Paul J Jr (1951-2021) Deaths (Obituaries) Legal Profession Suits and Litigation (Civil) Opioids and Opiates OxyContin (Drug) Pain-Relieving Drugs Drugs (Pharmaceuticals) Liability for Products Source Type: news

Oxycodone vs. OxyContin
Title: Oxycodone vs. OxyContinCategory: Diseases and ConditionsCreated: 5/17/2021 12:00:00 AMLast Editorial Review: 5/17/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 17, 2021 Category: Drugs & Pharmacology Source Type: news

Bessemer Couple Sentenced for Producing Fake Prescription Drugs
FDA OCI, Earnest Coleman, Tashana Sims, sentence, pill presses, fake prescription drugs, punches, dies, plates, defraud, mislead, powders, dyes, China, acetaminophen, fentanyl, heroin, paverine, fake Lortab, fake Adderall, fake Soma, fake Xanax, fake Ecstasy, fake Oxycodone, fake OxyContin, opioids, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - May 12, 2021 Category: Medical Law Authors: DOJ Source Type: news

Percodan (aspirin and oxycodone hydrochloride)
Title: Percodan (aspirin and oxycodone hydrochloride)Category: MedicationsCreated: 5/7/2021 12:00:00 AMLast Editorial Review: 5/7/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 7, 2021 Category: Drugs & Pharmacology Source Type: news

InFocus: The Misuse Potential of Oxycodone
No abstract available (Source: Emergency Medicine News)
Source: Emergency Medicine News - May 1, 2021 Category: Emergency Medicine Tags: InFocus Source Type: news

Empire of Pain — the story of the Sacklers and OxyContin
Patrick Radden Keefe’s saga of how a pharmaceutical dynasty unleashed a wave of dependency and grew rich from it (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 28, 2021 Category: Pharmaceuticals Source Type: news

Two novel biobanks offer investigatory targets for cocaine and oxycodone addiction
(University of California - San Diego) Researchers have created to novel biobanks of diverse tissues from animals to further explore the biological bases and consequences of addiction to cocaine and oxycodone. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 26, 2021 Category: International Medicine & Public Health Source Type: news

The Case for Abandoning ‘Corporate Responsibility’ When We Judge Company Practices
In an earlier era, green referred to grass and trees and jealous eyes. But over the past half-century, green has taken on a life of its own. The Green movement deals with the collisions and contagions of the contemporary world—how to view them, and how to cure them. The book from which this essay is excerpted, The Spirit of Green, examines a wide array of social, economic and political questions from a Green vantage point. These questions include established areas such as pollution control and global warming. But they also involve new frontiers such as Green chemistry, taxes, ethics and finance. The example that foll...
Source: TIME: Science - April 20, 2021 Category: Science Authors: William Nordhaus Tags: Uncategorized climate change feature Magazine TIME 2030 Source Type: news

For Him, the Delight Is in the Digging
Patrick Radden Keefe has investigated human smuggling, government espionage and the Northern Ireland conflict. With “Empire of Pain,” he takes on the Sackler family and the opioid crisis. (Source: NYT Health)
Source: NYT Health - April 8, 2021 Category: Consumer Health News Authors: MJ Franklin Tags: Books and Literature Empire of Pain: The Secret History of the Sackler Dynasty (Book) Keefe, Patrick Radden Opioids and Opiates Purdue Pharma Sackler Family Drug Abuse and Traffic OxyContin (Drug) Source Type: news

People Are Buying Illegal Opioids on the Dark Web
FRIDAY, April 2, 2021 -- Illegal drug sales on the dark web are common, hard to detect and are fueling America's opioid epidemic, a University of Texas study reveals. Opioids include prescription painkillers (such as oxycodone) and illegal drugs... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 2, 2021 Category: General Medicine Source Type: news

InFocus: The Saga of OxyContin
No abstract available (Source: Emergency Medicine News)
Source: Emergency Medicine News - April 1, 2021 Category: Emergency Medicine Tags: InFocus Source Type: news

Judge Blocks Lawsuits Against Sackler Family As OxyContin Bankruptcy Talks Continue
Two dozen states had hoped to sue the owners of Purdue Pharma for their alleged role in the opioid crisis. But a federal bankruptcy has judge put the brakes on — again — until April 21.(Image credit: Toby Talbot/AP) (Source: NPR Health and Science)
Source: NPR Health and Science - March 24, 2021 Category: Consumer Health News Authors: Brian Mann Source Type: news

Opioid Maker Purdue Pharma Files Bankruptcy Plan
TUESDAY, March 16, 2021 -- Purdue Pharma has filed a bankruptcy restructuring plan that seeks to end thousands of lawsuits over the role that its painkiller Oxycontin played in the U.S. opioid epidemic. The plan requires members of the Sackler... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 16, 2021 Category: Pharmaceuticals Source Type: news

Purdue Pharma Offers Plan to End Sackler Control and Mounting Lawsuits
The OxyContin maker filed its long-awaited restructuring plan in bankruptcy court. Revenue from the new company would go exclusively to abating the opioid crisis. (Source: NYT Health)
Source: NYT Health - March 16, 2021 Category: Consumer Health News Authors: Jan Hoffman and Mary Williams Walsh Tags: Suits and Litigation (Civil) Bankruptcies Opioids and Opiates OxyContin (Drug) Purdue Pharma Sackler Family Source Type: news

Hudson Woman Sentenced to 15 Months for Tampering with Consumer Products and Unlawfully Obtaining Controlled Substances
FDA OCI, Kristina Coleman, Hudson NH, sentence, tampering, opioid, pharmacy technician, Nashua, oxycodone, baclofen, suboxone, muscle relaxant, replacement, controlled substance, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - March 2, 2021 Category: Medical Law Authors: DOJ Source Type: news

Study shows opioid use among US patients with knee osteoarthritis costs 14 billion dollars in societal costs
(Wiley) Although guidelines do not recommend use of opioids to manage pain for individuals with knee osteoarthritis, a recent study published early online in Arthritis Care& Research, an official journal of the American College of Rheumatology and the Association of Rheumatology Professionals, estimates that 858,000 Americans use opioids such as tramadol and oxycodone for their knee pain, equating to $14 billion in lifetime opioid-related societal costs, or nearly $0.5 billion annually. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 25, 2021 Category: International Medicine & Public Health Source Type: news

Head of McKinsey, Kevin Sneader, Voted Out as Firm Faces Reckoning on Opioid Crisis
Partners decided not to keep Kevin Sneader in the top job. Weeks earlier, McKinsey had reached a historic settlement agreement in the U.S. over its advice to drugmakers. (Source: NYT Health)
Source: NYT Health - February 24, 2021 Category: Consumer Health News Authors: Michael Forsythe Tags: McKinsey & Co Sneader, Kevin David Appointments and Executive Changes Opioids and Opiates OxyContin (Drug) Purdue Pharma Source Type: news

Dark Web Trafficker Pleads Guilty to Distributing Opioids
FDA OCI, Daren Reid, Ft. Lauderdale FL, guilty, distribute, opioids, dark web, Oxyflight, Imperial Royalty, oxycodone, morphine, Silk Road, Wall Street, Apollon, drug trafficking, prescription drugs, Bitcoin, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - February 12, 2021 Category: Medical Law Authors: DOJ Source Type: news

Mexico ’s poor have little luck obtaining opioids intended for palliative care
If you ’re poor and terminally ill in southern Mexico, there’s far less chance you’ll get the painkillers you need for palliative care than your cousins in more prosperous regions, particularly those pharmacy-rich areas along Mexico–U.S. border, say UCLA researchers and colleagues who studied opioi d dispensing levels across the country.What ’s more, the researchers’ paper in the journalThe Lancet Public Health suggests it ’s likely that some of the opioids intended for Mexican citizens are ending up in American pockets.Despite a Mexican government initiative launched in 2015 to im...
Source: UCLA Newsroom: Health Sciences - February 11, 2021 Category: Universities & Medical Training Source Type: news

Abuse-deterrent extended-release oxycodone and risk of opioid-related harm - Paljarvi T, Strang J, Quinn PD, Luciano S, Fazel S.
AIM: To establish and quantify the association between abuse-deterrent formulation (ADF) oxycodone and 1-year risk of opioid-related harm. DESIGN: Propensity score-matched cohort study of electronic medical records for years 2014 - 2018, with pat... (Source: SafetyLit)
Source: SafetyLit - January 6, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Sacklers Apologize but Deflect Blame at US  Congressional Opioid Hearing Sacklers Apologize but Deflect Blame at US  Congressional Opioid Hearing
Two members of the wealthy Sackler family who own OxyContin maker Purdue offered apologies on Thursday for the role the prescription painkiller has played in the deadly US opioid epidemic.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 18, 2020 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

Sacklers Face Furious Questions in Rare Testimony on Opioid Epidemic
It was the first time in years that members of the family that owns Purdue Pharma have taken questions publicly, but they continued to deny personal responsibility for the decades-long addiction crisis. (Source: NYT Health)
Source: NYT Health - December 18, 2020 Category: Consumer Health News Authors: Jan Hoffman Tags: Sackler Family Purdue Pharma Addiction (Psychology) Opioids and Opiates OxyContin (Drug) Pain-Relieving Drugs Sackler, David Sackler, Kathe Drug Abuse and Traffic House Committee on Oversight and Government Reform House of Representati Source Type: news

Sacklers Deny Personal Responsibility for Opioid Epidemic in House Hearing
It was the first time in years that members of the family that owns Purdue Pharma have taken questions publicly, and the exchanges were tense. (Source: NYT Health)
Source: NYT Health - December 18, 2020 Category: Consumer Health News Authors: Jan Hoffman Tags: United States Politics and Government Addiction (Psychology) Opioids and Opiates OxyContin (Drug) House of Representatives Purdue Pharma Sackler Family Sackler, David Sackler, Kathe Drug Abuse and Traffic your-feed-healthcare Source Type: news

Family behind OxyContin attests to its role in opioid crisis
Two members of the Sackler family that owns OxyContin maker Purdue Pharma have acknowledged the drug had a role in the opioid epidemic (Source: ABC News: Health)
Source: ABC News: Health - December 17, 2020 Category: Consumer Health News Tags: Health Source Type: news

Members of family that led maker of OxyContin deny responsibility for opioid crisis in congressional hearing
This was the first time in decades that members of the Sackler family that led OxyContin maker Purdue Pharma testified in public under oath. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - December 17, 2020 Category: Consumer Health News Authors: Meryl Kornfield Source Type: news

Senate Report: The Opioid Industry Has Paid Advocacy Groups $65 Million
A bipartisan congressional investigation released Wednesday found that key players in the nation’s opioid industry have spent $65 million since 1997 funding nonprofits that advocate treating pain with medications, a strategy intended to boost the sale of prescription painkillers. The report from Sens. Chuck Grassley of Iowa and Ron Wyden of Oregon found the contributions continued in recent years, even as the industry’s practices and the toll of opioid addiction came under greater scrutiny. The senators, the top Republican and Democrat on the Senate Finance Committee, are considering legislation to expand an ex...
Source: TIME: Health - December 17, 2020 Category: Consumer Health News Authors: GEOFF MULVIHILL / AP Tags: Uncategorized Drugs overnight wire Source Type: news

Little Change Seen in Rx of Opioids for Those at Risk for Misuse
After CDC guideline publication, there was a 14 percent decrease in oxycodone prescriptions, but not for other Schedule II opioids (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - December 16, 2020 Category: Psychiatry Tags: Family Medicine, Gynecology, Internal Medicine, Emergency Medicine, Orthopedics, Pharmacy, Psychiatry, Surgery, Anesthesiology & amp; Pain, Journal, Source Type: news

McKinsey issues a rare apology for its role in OxyContin sales
Facing mounting pressure about its role in the opioid crisis, McKinsey has taken the unusual step of acknowledging that its work with Purdue Pharma fell short of its standards and vowed a full internal review of its actions, including the possible destruction of documents. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 9, 2020 Category: Biotechnology Authors: Walt Bogdanich and Michael Forsythe Source Type: news

McKinsey Issues a Rare Apology for Its Role in OxyContin Sales
The firm faced criticism after a report revealed that consultants had discussed destroying documents related to the opioid business and proposed that a drugmaker pay its distributors rebates for overdoses. (Source: NYT Health)
Source: NYT Health - December 8, 2020 Category: Consumer Health News Authors: Walt Bogdanich and Michael Forsythe Tags: Pain-Relieving Drugs Opioids and Opiates OxyContin (Drug) Drugs (Pharmaceuticals) Drug Abuse and Traffic McKinsey & Purdue Pharma House of Representatives Senate Hawley, Josh D (1979- ) Murphy, Philip D (1957- ) Schatz, Brian Source Type: news

New Guidelines Cover Opioid Use After Children ’s Surgery
Parents should not be afraid of managing the child ’s pain with opioids when they are needed, but should make sure a child does not have access to leftover doses. (Source: NYT Health)
Source: NYT Health - November 30, 2020 Category: Consumer Health News Authors: Perri Klass, M.D. Tags: Opioids and Opiates Pain-Relieving Drugs Children and Childhood Parenting Surgery and Surgeons Drug Abuse and Traffic OxyContin (Drug) Drugs (Pharmaceuticals) Source Type: news

McKinsey Proposed Paying Pharmacy Companies Rebates for OxyContin Overdoses
Court filings reveal consultants ’ talk of a records purge during the opioid crisis, and shed new light on sales advice given to the billionaire Sackler family and their drug company, Purdue Pharma. (Source: NYT Health)
Source: NYT Health - November 28, 2020 Category: Consumer Health News Authors: Walt Bogdanich and Michael Forsythe Tags: Pain-Relieving Drugs Suits and Litigation (Civil) Drugs (Pharmaceuticals) OxyContin (Drug) Opioids and Opiates Deaths (Fatalities) Drug Abuse and Traffic McKinsey & Purdue Pharma CVS Caremark Corporation Food and Drug Administration Source Type: news

'Is anybody in there?' Life on the inside as a locked-in patient
Jake Haendel spent months trapped in his body, silent and unmoving but fully conscious. Most people never emerge from ‘locked-in syndrome’, but as a doctor told him, everything about his case is bizarreJake Haendel was a hard-partying chef from a sleepy region of Massachusetts. When he was 28, his heroin addiction resulted in catastrophic brain damage and very nearly killed him. In a matter of months, Jake ’s existence became reduced to a voice in his head.Jake ’s parents had divorced when he was young. He grew up between their two homes in a couple of small towns just beyond reach of Boston, little...
Source: Guardian Unlimited Science - November 26, 2020 Category: Science Authors: Josh Wilbur Tags: Health Science Death and dying Coronavirus Source Type: news

Purdue Pharma Pleads Guilty Over Role in U.S. Opioid Epidemic
WEDNESDAY, Nov. 25, 2020 -- Purdue Pharma pleaded guilty to three criminal charges linked to the Oxycontin maker's role in the nation's opioid epidemic. In a virtual hearing Tuesday with a federal judge in Newark, New Jersey, Purdue admitted that it... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 25, 2020 Category: Pharmaceuticals Source Type: news

Purdue Pharma Pleads Guilty to Role in Opioid Crisis
The admission in federal court brought a formal end to a major investigation that resulted in a multibillion-dollar settlement between the drug maker and the government. (Source: NYT Health)
Source: NYT Health - November 25, 2020 Category: Consumer Health News Authors: Katie Benner Tags: Purdue Pharma OxyContin (Drug) Opioids and Opiates Drug Abuse and Traffic Sackler Family Compensation for Damages (Law) Justice Department Drug Enforcement Administration United States Politics and Government Suits and Litigation (Civil) Source Type: news

OxyContin maker Purdue Pharma pleads guilty to criminal charges
Purdue Pharma LP pleaded guilty to criminal charges over the handling of its addictive prescription painkiller OxyContin, capping a deal... (Source: Reuters: Health)
Source: Reuters: Health - November 24, 2020 Category: Consumer Health News Source Type: news

Purdue Pharma pleads guilty to federal criminal charges related to nation's opioid crisis
Purdue Pharma, the maker of OxyContin, pleaded guilty Tuesday to three federal criminal charges related to the company's role in... (Source: Reuters: Health)
Source: Reuters: Health - November 24, 2020 Category: Consumer Health News Source Type: news

OxyContin maker Purdue Pharma pleads guilty in criminal case
Purdue Pharma says its guilty plea over its role in the opioid crisis is “an essential step to preserve billions of dollars” for the settlement it is pursuing in bankruptcy court (Source: ABC News: Health)
Source: ABC News: Health - November 24, 2020 Category: Consumer Health News Tags: Health Source Type: news

OxyContin maker Purdue pleads guilty to charges related to opioid crisis
Purdue Pharma, the maker of OxyContin, pleaded guilty Tuesday to three criminal charges, formally admitting its role in an opioid epidemic that has contributed to hundreds of thousands of deaths over the past two decades. (Source: CBC | Health)
Source: CBC | Health - November 24, 2020 Category: Consumer Health News Tags: News/Health Source Type: news

OxyContin maker Purdue Pharma pleads guilty to federal criminal charges, formally admitting role in opioid crisis
(Source: ABC News: Health)
Source: ABC News: Health - November 24, 2020 Category: Consumer Health News Tags: Health Source Type: news